Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway

Oncol Lett. 2021 Mar;21(3):219. doi: 10.3892/ol.2021.12480. Epub 2021 Jan 21.

Abstract

[This retracts the article DOI: 10.3892/ol.2018.8086.].

Publication types

  • Retraction of Publication